Estrogen-containing oral contraceptives are allowable in young women with factor V Leiden heterozygosity without a history of thrombosis

Med Clin North Am. 2003 Nov;87(6):1225-36. doi: 10.1016/s0025-7125(03)00109-3.

Abstract

An 18-year-old woman without significant past medical and surgical history presents to discuss the safety and efficacy of oral contraceptives. She is sexually active and currently relying on condoms alone for birth control. Her cousin had a deep venous thrombosis (DVT) following a pregnancy. As part of the family screening, this patient was identified as a factor V Leiden heterozygote. The risks and benefits of initiating oral contraceptives are discussed.

Publication types

  • Case Reports
  • Clinical Conference

MeSH terms

  • Adolescent
  • Contraceptives, Oral / adverse effects
  • Contraceptives, Oral / pharmacology*
  • Estrogens / adverse effects
  • Estrogens / pharmacology*
  • Factor V*
  • Female
  • Heterozygote*
  • Humans
  • Medical Records
  • Thrombosis

Substances

  • Contraceptives, Oral
  • Estrogens
  • factor V Leiden
  • Factor V